Structure Therapeutics Inc.

GPCR

GPCRStructure Therapeutics Inc. US flag

NASDAQ Global Market

42.93

USD

-0.37

- -

2.47BMarket Cap

Profitability (USD)

MCP API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-53.39	-49.11	-30.91	-17.69	-11.35
Return on Capital (%)	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -	- -
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -
Operating Margin (%)	- -	- -	- -	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	- -
Profit Margin (%)	- -	- -	- -	- -	- -	- -
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	9.43	2.87	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -

Credit (USD)

MCP API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	1	- -	5	4	6
ST Debt	- -	- -	- -	1	2	3
LT Debt	- -	- -	- -	4	2	4
Total Debt/EBITDA	-0.02	-0.02	- -	-0.05	-0.02	-0.03
Net Debt/EBITDA	1.03	2.8	0.5	1.27	1.08	4.31
Total Debt/EBIT	-0.02	-0.02	- -	-0.05	-0.02	-0.03
Net Debt/EBIT	1.03	2.79	0.5	1.26	1.07	4.28
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-59.28	-58.24	-119.53	-42.85	-36.43	-29.69
Long-Term Debt/Equity (%)	- -	- -	- -	0.89	0.25	0.24
Long-Term Debt/Capital (%)	-0.59	-0.42	- -	-2	-0.67	-0.78
Long-Term Debt/Total Assets (%)	0.34	0.24	- -	0.83	0.24	0.23
Total Debt/Equity (%)	-1.25	-0.96	-0.23	1.2	0.45	0.43
Total Debt/Capital (%)	-1.24	-0.97	-0.22	-2.71	-1.19	-1.4
Total Debt/Total Assets (%)	0.72	0.56	0.27	1.13	0.43	0.41
Net Debt to Equity	72.78	162.67	22.66	-28.65	-19.6	-52.73
Net Debt/Capital (%)	41.91	62.16	18.27	39.22	34.26	63.29
EBITDA	-16	-38	-52	-102	-157	-185
EBITDA-CapEx	-16	-39	-52	-105	-159	-189
Operating Income (Loss)	-16	-38	-53	-103	-158	-187

Liquidity (USD)

MCP API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	12.32	12.39	6.98	18.89	24.53	22.85
Current Ratio	12.64	12.62	7.16	19.14	24.74	24.81
Quick Ratio	12.32	12.39	6.98	18.89	24.53	24.43
CFO/Avg Current Liab	- -	-5.5	-4.26	-4.21	-3.84	-4.48
Common Equity/Total Assets	-59.28	-58.24	-119.53	-42.85	-36.43	-29.69
Long-Term Debt/Equity (%)	- -	- -	- -	0.89	0.25	0.24
Long-Term Debt/Capital (%)	-0.59	-0.42	- -	-2	-0.67	-0.78
Long-Term Debt/Total Assets (%)	0.34	0.24	- -	0.83	0.24	0.23
Total Debt/Equity (%)	-1.25	-0.96	-0.23	1.2	0.45	0.43
Total Debt/Capital (%)	-1.24	-0.97	-0.22	-2.71	-1.19	-1.4
Total Debt/Total Assets (%)	0.72	0.56	0.27	1.13	0.43	0.41
CFO/Total Liabilities	-23.35	-18.28	-21.65	-273.62	-303.05	-328.98
CFO/CapEx	-751.74	-26.67	-297.55	-36.68	-90.42	-61.48
Altman's Z-Score	-1.09	-0.85	-2.46	30.74	24.27	44.1

Working Capital (USD)

MCP API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

MCP API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	1,497	1,554	4,927
- Cash & Cash Equivalents	16	105	26	130	170	800
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	1	- -	5	4	6
Enterprise Value	-37	-107	-91	1,035	674	3,487
Total Capital	-23	-64	-117	-201	-325	-464
Total Debt/Capital (%)	-1.24	-0.97	-0.22	-2.71	-1.19	-1.4
Total Debt / EV	-0.01	-0.01	- -	0.01	0.01	- -
EV/Sales	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	1,497	1,554	4,927
Diluted Enterprise Value	-16	-105	-26	1,373	1,388	4,134
EV per Share	- -	- -	- -	28.19	11.76	49.23
TTM Sales	- -	- -	- -	- -	- -	- -
TTM EBITDA	-16	-38	-52	-102	-157	-185
TTM Operating Income	-16	-38	-53	-103	-158	-187
TTM Cash Flow to Firm	-14	-32	-46	-79	-117	-222
TTM Free Cash Flow to Firm	-14	-31	-46	-77	-115	-219

Multiples (USD)

MCP API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	-19.36	-13.47	-22.54
EV/EBIT	- -	- -	- -	- -	- -	- -
Enterprise Value	-37	-107	-91	1,035	674	3,487
Low Price	- -	- -	- -	20.8	25.9	13.22
EV/Sales	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	-14.96	-18.38	-13.49
Price/Earnings High	- -	- -	- -	-30.75	-29.33	-47.61
Price/Earnings Low	- -	- -	- -	-8.53	-12.11	-6.63
Price/Book Value	- -	- -	- -	-7.25	-4.72	-10.48
Price/Book Value Average	- -	- -	- -	-6.49	-6.84	-4.05
Price/Book Value High	- -	- -	- -	-13.34	-10.92	-14.29
Price/Book Value Low	- -	- -	- -	-3.7	-4.51	-1.99
Price/Tangible Book Value	- -	- -	- -	3.31	1.8	3.25
Price/Tangible Book Value Average	- -	- -	- -	2.96	2.6	1.26
Price/Tangible Book Value High	- -	- -	- -	6.08	4.16	4.43
Price/Tangible Book Value Low	- -	- -	- -	1.69	1.72	0.62
Price/Sales	- -	- -	- -	- -	- -	- -
Price/Sales Average	- -	- -	- -	- -	- -	- -
Price/Sales High	- -	- -	- -	- -	- -	- -
Price/Sales Low	- -	- -	- -	- -	- -	- -
Price/Cash Flow	- -	- -	- -	-18.84	-13.32	-22.17
Price/Cash Flow Average	- -	- -	- -	-16.86	-19.3	-8.57
Price/Cash Flow High	- -	- -	- -	-34.67	-30.82	-30.25
Price/Cash Flow Low	- -	- -	- -	-9.61	-12.72	-4.21
Price/Free Cash Flow Average	- -	- -	- -	-17.34	-19.52	-8.71
Price/Free Cash Flow High	- -	- -	- -	-35.64	-31.16	-30.75
Price/Free Cash Flow Low	- -	- -	- -	-9.88	-12.86	-4.28
EV/Sales Average	- -	- -	- -	- -	- -	- -
EV/Sales High	- -	- -	- -	- -	- -	- -
EV/Sales Low	- -	- -	- -	- -	- -	- -
EV/EBITDA Average	1.01	2.78	0.49	-11.87	-13.27	-5.99
EV/EBITDA High	1.01	2.78	0.49	-25.68	-21.8	-31.97
EV/EBITDA Low	1.01	2.78	0.49	-6.24	-8.38	-0.77
EV/EBIT Average	1.01	2.78	0.49	-11.83	-13.18	-5.95
EV/EBIT High	1.01	2.78	0.49	-25.6	-21.67	-31.74
EV/EBIT Low	1.01	2.78	0.49	-6.22	-8.33	-0.77
Last Price	- -	- -	- -	40.76	27.12	69.55
High Price	- -	- -	- -	75.02	62.74	94.9
Enterprise Value Average	-16	-105	-26	1,216	2,086	1,111
Enterprise Value High	-16	-105	-26	2,631	3,429	5,929
Enterprise Value Low	-16	-105	-26	640	1,318	143

Profitability (USD)

MCP API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-53.39	-49.11	-30.91	-17.69	-11.35
Return on Capital (%)	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -	- -
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -
Operating Margin (%)	- -	- -	- -	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	- -
Profit Margin (%)	- -	- -	- -	- -	- -	- -
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	9.43	2.87	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -

Credit (USD)

MCP API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	1	- -	5	4	6
ST Debt	- -	- -	- -	1	2	3
LT Debt	- -	- -	- -	4	2	4
Total Debt/EBITDA	-0.02	-0.02	- -	-0.05	-0.02	-0.03
Net Debt/EBITDA	1.03	2.8	0.5	1.27	1.08	4.31
Total Debt/EBIT	-0.02	-0.02	- -	-0.05	-0.02	-0.03
Net Debt/EBIT	1.03	2.79	0.5	1.26	1.07	4.28
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-59.28	-58.24	-119.53	-42.85	-36.43	-29.69
Long-Term Debt/Equity (%)	- -	- -	- -	0.89	0.25	0.24
Long-Term Debt/Capital (%)	-0.59	-0.42	- -	-2	-0.67	-0.78
Long-Term Debt/Total Assets (%)	0.34	0.24	- -	0.83	0.24	0.23
Total Debt/Equity (%)	-1.25	-0.96	-0.23	1.2	0.45	0.43
Total Debt/Capital (%)	-1.24	-0.97	-0.22	-2.71	-1.19	-1.4
Total Debt/Total Assets (%)	0.72	0.56	0.27	1.13	0.43	0.41
Net Debt to Equity	72.78	162.67	22.66	-28.65	-19.6	-52.73
Net Debt/Capital (%)	41.91	62.16	18.27	39.22	34.26	63.29
EBITDA	-16	-38	-52	-102	-157	-185
EBITDA-CapEx	-16	-39	-52	-105	-159	-189
Operating Income (Loss)	-16	-38	-53	-103	-158	-187

Liquidity (USD)

MCP API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	12.32	12.39	6.98	18.89	24.53	22.85
Current Ratio	12.64	12.62	7.16	19.14	24.74	24.81
Quick Ratio	12.32	12.39	6.98	18.89	24.53	24.43
CFO/Avg Current Liab	- -	-5.5	-4.26	-4.21	-3.84	-4.48
Common Equity/Total Assets	-59.28	-58.24	-119.53	-42.85	-36.43	-29.69
Long-Term Debt/Equity (%)	- -	- -	- -	0.89	0.25	0.24
Long-Term Debt/Capital (%)	-0.59	-0.42	- -	-2	-0.67	-0.78
Long-Term Debt/Total Assets (%)	0.34	0.24	- -	0.83	0.24	0.23
Total Debt/Equity (%)	-1.25	-0.96	-0.23	1.2	0.45	0.43
Total Debt/Capital (%)	-1.24	-0.97	-0.22	-2.71	-1.19	-1.4
Total Debt/Total Assets (%)	0.72	0.56	0.27	1.13	0.43	0.41
CFO/Total Liabilities	-23.35	-18.28	-21.65	-273.62	-303.05	-328.98
CFO/CapEx	-751.74	-26.67	-297.55	-36.68	-90.42	-61.48
Altman's Z-Score	-1.09	-0.85	-2.46	30.74	24.27	44.1

Working Capital (USD)

MCP API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

MCP API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	1,497	1,554	4,927
- Cash & Cash Equivalents	16	105	26	130	170	800
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	1	- -	5	4	6
Enterprise Value	-37	-107	-91	1,035	674	3,487
Total Capital	-23	-64	-117	-201	-325	-464
Total Debt/Capital (%)	-1.24	-0.97	-0.22	-2.71	-1.19	-1.4
Total Debt / EV	-0.01	-0.01	- -	0.01	0.01	- -
EV/Sales	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	1,497	1,554	4,927
Diluted Enterprise Value	-16	-105	-26	1,373	1,388	4,134
EV per Share	- -	- -	- -	28.19	11.76	49.23
TTM Sales	- -	- -	- -	- -	- -	- -
TTM EBITDA	-16	-38	-52	-102	-157	-185
TTM Operating Income	-16	-38	-53	-103	-158	-187
TTM Cash Flow to Firm	-14	-32	-46	-79	-117	-222
TTM Free Cash Flow to Firm	-14	-31	-46	-77	-115	-219

Multiples (USD)

MCP API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	-19.36	-13.47	-22.54
EV/EBIT	- -	- -	- -	- -	- -	- -
Enterprise Value	-37	-107	-91	1,035	674	3,487
Low Price	- -	- -	- -	20.8	25.9	13.22
EV/Sales	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	-14.96	-18.38	-13.49
Price/Earnings High	- -	- -	- -	-30.75	-29.33	-47.61
Price/Earnings Low	- -	- -	- -	-8.53	-12.11	-6.63
Price/Book Value	- -	- -	- -	-7.25	-4.72	-10.48
Price/Book Value Average	- -	- -	- -	-6.49	-6.84	-4.05
Price/Book Value High	- -	- -	- -	-13.34	-10.92	-14.29
Price/Book Value Low	- -	- -	- -	-3.7	-4.51	-1.99
Price/Tangible Book Value	- -	- -	- -	3.31	1.8	3.25
Price/Tangible Book Value Average	- -	- -	- -	2.96	2.6	1.26
Price/Tangible Book Value High	- -	- -	- -	6.08	4.16	4.43
Price/Tangible Book Value Low	- -	- -	- -	1.69	1.72	0.62
Price/Sales	- -	- -	- -	- -	- -	- -
Price/Sales Average	- -	- -	- -	- -	- -	- -
Price/Sales High	- -	- -	- -	- -	- -	- -
Price/Sales Low	- -	- -	- -	- -	- -	- -
Price/Cash Flow	- -	- -	- -	-18.84	-13.32	-22.17
Price/Cash Flow Average	- -	- -	- -	-16.86	-19.3	-8.57
Price/Cash Flow High	- -	- -	- -	-34.67	-30.82	-30.25
Price/Cash Flow Low	- -	- -	- -	-9.61	-12.72	-4.21
Price/Free Cash Flow Average	- -	- -	- -	-17.34	-19.52	-8.71
Price/Free Cash Flow High	- -	- -	- -	-35.64	-31.16	-30.75
Price/Free Cash Flow Low	- -	- -	- -	-9.88	-12.86	-4.28
EV/Sales Average	- -	- -	- -	- -	- -	- -
EV/Sales High	- -	- -	- -	- -	- -	- -
EV/Sales Low	- -	- -	- -	- -	- -	- -
EV/EBITDA Average	1.01	2.78	0.49	-11.87	-13.27	-5.99
EV/EBITDA High	1.01	2.78	0.49	-25.68	-21.8	-31.97
EV/EBITDA Low	1.01	2.78	0.49	-6.24	-8.38	-0.77
EV/EBIT Average	1.01	2.78	0.49	-11.83	-13.18	-5.95
EV/EBIT High	1.01	2.78	0.49	-25.6	-21.67	-31.74
EV/EBIT Low	1.01	2.78	0.49	-6.22	-8.33	-0.77
Last Price	- -	- -	- -	40.76	27.12	69.55
High Price	- -	- -	- -	75.02	62.74	94.9
Enterprise Value Average	-16	-105	-26	1,216	2,086	1,111
Enterprise Value High	-16	-105	-26	2,631	3,429	5,929
Enterprise Value Low	-16	-105	-26	640	1,318	143

Shares Outstanding	115	115	115	139	172	213
Diluted Weighted Avg Shares	25	25	38	37	57	71
Basic Weighted Avg Shares	25	25	38	37	57	71
Revenue per Share	- -	- -	- -	- -	- -	- -
EBITDA per Share	-0.63	-1.48	-1.37	-2.79	-2.74	-2.62
Operating Income per Share	-0.63	-1.48	-1.37	-2.8	-2.76	-2.64
Basic EPS, GAAP	-0.64	-1.72	-1.38	-2.44	-2.14	-1.99
Basic EPS from Cont Ops	-0.63	-1.49	-1.34	-2.44	-2.14	-1.99
Diluted EPS, GAAP	-0.64	-1.72	-1.38	-2.44	-2.14	-1.99
Diluted EPS from Cont Ops	-0.63	-1.49	-1.34	-2.44	-2.14	-1.99
Dividend per Share	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.57	-1.26	-1.21	-2.16	-2.04	-3.14
Free Cash Flow per Basic Share	-0.57	-1.31	-1.21	-2.22	-2.06	-3.19
Cash & Equivalents per Share	1.49	4.21	2.38	12.72	15.42	20.42
Book Value per Share	-0.92	-2.54	-3.06	-5.62	-5.74	-6.64
Tangible Book Value per Share	-0.9	-2.54	-3.01	12.33	15.1	21.41

Structure Therapeutics Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)